Machine learning techniques to predict diabetic ketoacidosis and HbA1c above 7% among individuals with type 1 diabetes - A large multi-centre study in Australia and New Zealand.
Arul Earnest, Timothy W Jones, Melissa Chee, Deborah J Holmes-Walker
{"title":"Machine learning techniques to predict diabetic ketoacidosis and HbA1c above 7% among individuals with type 1 diabetes - A large multi-centre study in Australia and New Zealand.","authors":"Arul Earnest, Timothy W Jones, Melissa Chee, Deborah J Holmes-Walker","doi":"10.1016/j.numecd.2025.103861","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Type 1 diabetes and diabetic ketoacidosis (DKA) have a significant impact on individuals and society across a wide spectrum. Our objective was to utilize machine learning techniques to predict DKA and HbA1c>7 %.</p><p><strong>Methods and results: </strong>Nine different models were implemented and model performance evaluated via the Area under the Curve (AUC). These models were applied to a large multi-centre dataset of 13761 type 1 diabetes individuals prospectively recruited from Australia and New Zealand. Predictive features included a number of clinical demographic and socio-economic measures collected at previous visits. In our study, 2.9 % reported at least one episode of DKA since their last clinic visit. A number of features were significantly associated with DKA. Our results showed that Deep Learning (DL) model performed well in predicting DKA with an AUC of 0.887. The DL also provided the lowest classification error rate of 0.9 %, highest sensitivity of 99.9 % and F-measure of 99.6 %. As for HbA1c >7 %, the optimal Support Vector Machine provided a good AUC of 0.884.</p><p><strong>Conclusion: </strong>Machine learning models can be effectively implemented on real-life large clinical datasets and they perform well in terms of identifying individuals with type 1 diabetes at risk of adverse outcomes.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"103861"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition Metabolism and Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.numecd.2025.103861","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims: Type 1 diabetes and diabetic ketoacidosis (DKA) have a significant impact on individuals and society across a wide spectrum. Our objective was to utilize machine learning techniques to predict DKA and HbA1c>7 %.
Methods and results: Nine different models were implemented and model performance evaluated via the Area under the Curve (AUC). These models were applied to a large multi-centre dataset of 13761 type 1 diabetes individuals prospectively recruited from Australia and New Zealand. Predictive features included a number of clinical demographic and socio-economic measures collected at previous visits. In our study, 2.9 % reported at least one episode of DKA since their last clinic visit. A number of features were significantly associated with DKA. Our results showed that Deep Learning (DL) model performed well in predicting DKA with an AUC of 0.887. The DL also provided the lowest classification error rate of 0.9 %, highest sensitivity of 99.9 % and F-measure of 99.6 %. As for HbA1c >7 %, the optimal Support Vector Machine provided a good AUC of 0.884.
Conclusion: Machine learning models can be effectively implemented on real-life large clinical datasets and they perform well in terms of identifying individuals with type 1 diabetes at risk of adverse outcomes.
期刊介绍:
Nutrition, Metabolism & Cardiovascular Diseases is a forum designed to focus on the powerful interplay between nutritional and metabolic alterations, and cardiovascular disorders. It aims to be a highly qualified tool to help refine strategies against the nutrition-related epidemics of metabolic and cardiovascular diseases. By presenting original clinical and experimental findings, it introduces readers and authors into a rapidly developing area of clinical and preventive medicine, including also vascular biology. Of particular concern are the origins, the mechanisms and the means to prevent and control diabetes, atherosclerosis, hypertension, and other nutrition-related diseases.